TriCalm Hydrogel for Itching from Immunotherapy
Part of Skin clinical trials.
This trial tests a gel called TriCalm Hydrogel to see if it helps reduce itching caused by immunotherapy cancer treatment. If you have itching from your immunotherapy, this study might offer relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are getting immunotherapy for cancer at UC San Diego's Moores Cancer Center.
- You have developed mild to moderate itching after at least one dose of immunotherapy.
- You do not have a skin condition like eczema or psoriasis that causes itching.
- You have not started new anti-itch pills or creams in the last 7 days.
- Your itching is not on your face.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks blood antibodies (BP180 and BP230) in people who develop long-lasting itching after starting immune therapy for cancer. It may help doctors understand why the itching happens and how it relates to autoimmune skin conditions.
This trial tests whether a medicine called aprepitant can reduce itching caused by immunotherapy drugs in people with solid tumors. If you have bothersome itching that won't go away, this treatment might help.
This trial tests if dupilumab (Dupixent) can help adults with long-lasting, severe itching from healed burn scars. It is for people whose itching has not improved with standard treatments like antihistamines.
This study looks at how certain proteins and channels in the body affect pain and itching. Healthy people will have a small test area on their forearm treated with a study drug to see if it changes how they feel pain or itch.
This study tests a new gel called VC005 to see if it safely reduces itching, redness, and irritation in people with atopic dermatitis (a chronic skin condition). You'll be randomly assigned to either the new gel or a placebo (inactive gel) and apply it to affected areas over several weeks.
This trial tests an investigational drug called ATTO-1310 to see if it can reduce chronic itching that has no clear cause. It may help people who have tried antihistamines without success.
Hear when a new Immunotherapy-related Pruritus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.